LGALS9 and rheumatoid arthritis: However, there was no significant difference in serum Gal-9 between RA patients with and without shorter disease durations (less than 5 years, 7009 pg/ml [IQR 5134–4527] versus 5 years or more, 7886 pg/ml [IQR 6154–10,692], p = 0.40).